SCHEMBL7015033

SCHEMBL7015033

CCc1cc2c(=O)c3cccc(C(=O)OC)c3n(Cc3ccc(-c4ccccc4-c4nnn[nH]4)cc3)c2s1

nearest known ligand 0.49

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 15/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7007755 0.92 AGTR1 (0.49) AGTR1
SCHEMBL7009180 0.89 AGTR1 (0.46) AGTR1
SCHEMBL7012215 0.84 AGTR1 (0.53) AGTR1
SCHEMBL7013028 0.82 AGTR1 (0.49) AGTR1
SCHEMBL9044284 0.78 AGTR1 (0.43) AGTR1
SCHEMBL9044702 0.78 AGTR1 (0.46) AGTR1
SCHEMBL9044761 0.77 AGTR1 (0.42) AGTR1
SCHEMBL9194238 0.77
SCHEMBL7007439 0.77 AGTR1 (0.42) AGTR1
SCHEMBL9049056 0.77 AGTR1 (0.45) AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1327631-A2 Fused heterocyclic compounds, their production and use as angiotensin II antagonists Takeda Chemical Industries, Ltd. (JP) 2003-07-16 EP disclosed
EP-0518033-B1 Fused heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-07-02 EP disclosed
US-5389641-A Fused heterocyclic compounds, having angiotensin II antagonistic activity TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-02-14 US disclosed
EP-0518033-A1 Fused heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-12-16 EP disclosed